M&G Plc
- SEC CIK
- 0001802539
- Latest filing
- Aug 6, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by M&G Plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings
- Shares (Q2 2026)
- 88,261
- Value
- $14.9M
- % of portfolio
- 0.1%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 88,261 | $14.9M | 0.1% | −4,293−4.6% | Reduced | Holders |
| Q1 2026 | 92,554 | $12.2M | 0.1% | +955+1.0% | Added | Holders |
| Q4 2025 | 91,599 | $13.0M | 0.1% | +7,913+9.5% | Added | Holders |
| Q3 2025 | 83,686 | $11.7M | 0.1% | +83,686 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −69,026−100.0% | Sold out | Holders |
| Q1 2024 | 69,026 | $9.53M | 0.1% | – | No prior filing | Holders |